Active Molecules (423)
InChIKey pChEMBL Type Targets Clinical
IFLPDVNBLNGRJS 6.3 IC50 3
ZQTWZFDWESQAJC 6.3 IC50 4
BXYHVTNOOQQGIX 6.3 IC50 2
FRXASIJLUZANGQ 6.3 IC50 2
GQXFGAMRIGUNFT 6.3 IC50 4
IGUMGHXARYMDOH 6.3 IC50 2
KCQKBTOZPJUIOB 6.3 IC50 2
LPHBJUMXVNLVHV 6.3 IC50 2
MRQQFNYBBUPHBO 6.3 IC50 2
NBYRSQFPXVDWIQ 6.3 IC50 2
NGTZWJDYGGJQKX 6.3 IC50 2
OPPOJMZMKVHFTL 6.3 IC50 2
PNDGJHQRTNWFPM 6.3 IC50 2
RHSPRKGPTSPXAP 6.3 IC50 2
ULKSKTVRGTZGIO 6.3 IC50 2
UOSUHGQNSWCRRK 6.3 IC50 2
VPASADOBKPIPCJ 6.3 IC50 2
WFBXRHXEDPUNER 6.3 IC50 2
YHXHHOFQKNJLJS 6.3 IC50 2
XNRZMTWJFLFRMR 6.2 IC50 4
YHMNROQTPUKNLA 6.2 IC50 8
IBJLUHJBIGMOMD 6.2 IC50 4
HTSUQACFQAFQAC 6.2 IC50 2
SMYPWBHABVYAJK 6.2 IC50 2
YVDMZGMWMJONGA 6.2 IC50 2
XBQGLWPUGBREQS 6.2 IC50 4
KRAIKLYQMMJWDD 6.2 IC50 2
MYFFGZYMLKZBPZ 6.2 IC50 4
RHPSSUMJYGAMNR 6.2 IC50 3
YDFGIFLYGLMJSV 6.2 IC50 4
FAHTXQGZATYBQZ 6.2 IC50 2
HXGQYSSCVKIEIA 6.2 IC50 3
RLAHXCWDADVADO 6.2 IC50 4
FOLIJXOPRUSFGM 6.2 IC50 2
HBIBLLVDGBUKCQ 6.2 IC50 4
OICAHOQZWFDNHP 6.2 IC50 2
WHDUHJYPRJXLGF 6.2 Kd 4
ZXIJCVCJLDGJRX 6.2 IC50 2
IPJMGURQBOGYIE 6.2 IC50 4
MXCCPOZZBZEVAU 6.2 IC50 2
VLEMFHFORYINCB 6.2 IC50 4
LWGUCDPMTIPABX 6.1 IC50 4
XMZQWTVGYFDKCT 6.1 IC50 2
CPMTVMSTJKIGJI 6.1 IC50 4
WRUWGLUCNBMGPS 6.1 Kd 5
AKKOLAYSRGICKG 6.1 IC50 2
FEQUIPXIENTMJN 6.1 IC50 2
GAVLMQAIIHDXBG 6.1 IC50 2
APJDTDALQSVARU 6.1 IC50 3
OVLDCYAZEIXCEQ 6.1 IC50 4
2D structure